High‐efficiency delivery of CRISPR‐Cas9 by engineered probiotics enables precise microbiome editing
Abstract Antibiotic resistance threatens our ability to treat infectious diseases, spurring interest in alternative antimicrobial technologies. The use of bacterial conjugation to deliver CRISPR‐cas systems programmed to precisely eliminate antibiotic‐resistant bacteria represents a promising approa...
Guardado en:
Autores principales: | Kevin Neil, Nancy Allard, Patricia Roy, Frédéric Grenier, Alfredo Menendez, Vincent Burrus, Sébastien Rodrigue |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c9ddf6574182493ea5f2edf2a1f7117a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bioinformational analysis of Yersinia pseudotuberculosis IP32953 CRISPR/cas system
por: N. P. Peretolchina, et al.
Publicado: (2016) -
Development of a CRISPR/Cas9-Based Tool for Gene Deletion in <italic toggle="yes">Issatchenkia orientalis</italic>
por: Vinh G. Tran, et al.
Publicado: (2019) -
Conditional CRISPR-Cas Genome Editing in <i>Drosophila</i> to Generate Intestinal Tumors
por: Shivohum Bahuguna, et al.
Publicado: (2021) -
Disabling a Type I-E CRISPR-Cas Nuclease with a Bacteriophage-Encoded Anti-CRISPR Protein
por: April Pawluk, et al.
Publicado: (2017) -
Characterization of a Type II-A CRISPR-Cas System in <italic toggle="yes">Streptococcus mutans</italic>
por: Cas Mosterd, et al.
Publicado: (2020)